[ Back to EurekAlert! ]

Contact: Vanessa Pavinato
European Society for Medical Oncology

Nationwide NSCLC Study Provides Data on the Value of Molecular Screening for Targeted Treatment

Loading video...

Caption: R. Dziadziuszko underlines the importance of widening the range of screened biomarkers, the potential benefits in terms of treatment appropriateness for patients and the added value of broad collaborations. http://www.esmo.org

Credit: European Society for Medical Oncology

Usage Restrictions: None

[ Back to EurekAlert! ]